Last reviewed · How we verify
NCT03697499
Effects of Fish Oil in Alleviating Health Hazards Associated With Ozone Exposure
NA trial testing fish oil and acute ozone exposure in Cardiovascular System in 64 participants. Completed in 30 December 2019.
10 December 2018
Quick facts
| Lead sponsor | Fudan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 64 |
| Start date | 20 September 2018 |
| Primary completion | 10 December 2018 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- fish oil and acute ozone exposure
- fish oil and sham exposure
- soy oil and acute ozone exposure
- soy oil and sham exposure
Conditions studied
- Cardiovascular System — all drugs for Cardiovascular System →
- Respiratory System — all drugs for Respiratory System →
- Oxidative Stress — all drugs for Oxidative Stress →
- Inflammation — all drugs for Inflammation →
Sponsor
Fudan University
Who can join
Adults 18 to 30, any sex, with Cardiovascular System or Respiratory System. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate whether dietary supplementation with fish oil can protect against the cardiopulmonary effects induced by ozone exposure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03697499
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular System
Currently open trials in the same condition.
- NCT07501923 — The Effects of Daytime, Nighttime, and Combined Heat Exposure on Human Health · NA · recruiting
- NCT06652425 — Acute Effects of Cold Exposure on Cardiovascular System · NA · recruiting
- NCT05575752 — Acute Health Effects of High Temperature Exposure · NA · active not recruiting
- NCT04153539 — Acute Health Effects of Traffic-Related Air Pollution Exposure · NA · active not recruiting
Other Fudan University trials
Trials by the same sponsor.
- NCT06196671 — Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer · Phase 2 · not yet recruiting
- NCT07423611 — ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer · Phase 2 · not yet recruiting
- NCT07410559 — Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Bre · Phase 2 · not yet recruiting
- NCT07490119 — Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer · Phase 2 · not yet recruiting
- NCT07497919 — A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03697499 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fudan University
- Last refreshed: 5 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03697499.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing